Guardian Pharmacy Services, Inc.·4

Mar 3, 4:10 PM ET

Morris David K 4

4 · Guardian Pharmacy Services, Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardian Pharmacy (GRDN) CFO David K. Morris Receives Award

What Happened David K. Morris, Executive Vice President and Chief Financial Officer of Guardian Pharmacy Services, Inc. (GRDN), received an award of 8,952 restricted stock units (RSUs) on March 1, 2026. The Form 4 lists the transaction as an award/grant (code A) with an acquisition price of $0.00 — i.e., a compensation grant rather than an open-market purchase.

Key Details

  • Transaction date: March 1, 2026; Form 4 filed March 3, 2026 (timely filing).
  • Award: 8,952 RSUs reported at $0.00 (code A).
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnote: F1 — RSUs settle one-for-one into Class A common stock and vest in full on March 1, 2029.
  • No indication this was a sale, exercise, or tax-related withholding event.

Context RSUs are a form of equity compensation that convert to shares only upon vesting; these units do not represent immediately marketable shares and generate no cash proceeds upon grant. Such grants are routine for executives and reflect compensation arrangements rather than direct insider buying or selling activity.

Insider Transaction Report

Form 4
Period: 2026-03-01
Morris David K
DirectorSee Remarks
Transactions
  • Award

    Class A Common Stock

    [F1]
    2026-03-01+8,952442,327 total
Footnotes (1)
  • [F1]Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of Class A common stock, vesting in full on March 1, 2029.
Signature
/s/ Douglas Towns, Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    ownership.xmlPrimary

    4